Cough Science News
Find all editions of Cough Science News below and get access to the latest cough science developments, publications, and interviews with cough experts.
Find all editions of Cough Science News below and get access to the latest cough science developments, publications, and interviews with cough experts.
This month’s roundup explores placebo effects in RCC trials, the role of interoception in chronic cough, and the cost burden of persistent symptoms, plus insights from Dr. Nadia Giannetti.
New key cough science publications, Actigraph x Hyfe partnership and more
This year marked significant progress in cough monitoring, solidifying cough as a valuable biomarker in diverse therapeutic areas
New findings on refractory chronic cough (RCC), pulmonary tuberculosis, and pulmonary fibrosis. Plus latest white papers by Hyfe.
Cough Science News Oct 1 - new studies on cough-related stress urinary incontinence, COVID-19 detection in vaccinated adults, and the effectiveness of anti-reflux surgery for chronic cough. Plus, expert discussions from Hyfe's Cough Science Forum and the latest on FDA regulations for cough monitoring technologies
Cough Science News Oct 1 - new studies on cough-related stress urinary incontinence, COVID-19 detection in vaccinated adults, and the effectiveness of anti-reflux surgery for chronic cough. Plus, expert discussions from Hyfe's Cough Science Forum and the latest on FDA regulations for cough monitoring technologies
Cough Science News, August 2024 - Explore studies on cough variability, acute cough duration, and the cost burden of chronic cough. Plus, discover the world’s most comprehensive collection of cinematic coughs and upcoming events in cough science
CougH Science News July 2024 - latest in cough science. Insights on cough detection algorithms, pulmonary fibrosis, asthma diagnosis from cough sounds, and more. Plus, watch expert discussions and stay updated on upcoming events
Hyfe Cough Science News, June 2024. Latest research on cough in fibrotic ILD, high-dose inhaled corticosteroids for chronic cough, and family physicians’ approaches to managing chronic cough. Plus, insights from leading researchers and upcoming events
Cough Science News May 2024 - studies on cough monitoring for COVID-19 surveillance, the effectiveness of codeine for chronic cough, factors in refractory cough in IPF, and more. Plus, insights from researchers and upcoming events
Hyfe Cough Science News, March 2024 - insights on chronic cough management in the UK, common triggers in cough hypersensitivity, and a review of treatments for refractory cough. Plus, expert Q&A and upcoming cough science events.
Here’s What’s Inside
Key Takeaway: This study of 147 women with refractory/unexplained chronic cough found 44% of women experienced cough-related stress urinary-incontinence (SUI), and nearly half were undiagnosed. Both diagnosed and undiagnosed groups reported similar negative effects on their general health and quality of life, greater than was reported by those without cough-related SUI.
Why It Matters: By highlighting the underdiagnosis and significant impact of cough-related stress urinary incontinence (SUI) in women with chronic cough, this study points to the need for greater awareness and improved screening tools. It also suggests a need for cough-related SUI-targeted therapies.
Key Takeaway: Researcher investigated the effectiveness of fever as a diagnostic indicator of Covid-19 in vaccinated individuals. The study, conducted in Japan, found that vaccinated individuals were significantly less likely to experience fever compared to unvaccinated individuals. In contrast, cough and sore throat were more frequently observed in the vaccinated group.
Why It Matters: The study suggests that cough and sore throat may be more reliable indicators for COVID-19 in vaccinated individuals. The findings emphasize that relying on fever alone could lead to underdiagnosis in vaccinated populations.
Key Takeaways: This systematic review of 59 studies with 7,431 patients found that anti-reflux surgery offers long-term relief from gastroesophageal reflux disease (GERD) symptoms, particularly cough.
Why it matters: The study supports the use of anti-reflux surgery for patients with GERD symptoms, but also demonstrates the need for further research to identify predictors of success.
A Cough Science Forum Special
Watch Hyfe’s 8th Cough Science Forum, a quarterly Zoom event hosted by Hyfe that features recent and ongoing research in cough science, available via on-demand video.
Agenda: Internet behavioral cough suppression therapy: brief recap of a randomized, sham-treatment controlled trial. Speaker: Jane Reynolds PhD CCC-SLP, Assistant Professor University of Montana, Co-Director VOICES Lab
The use of real-time cough monitoring of acute exacerbations of pulmonary sarcoidosis: a pilot study. Speaker: Marc A. Judson, MD, Albany Medical College
It’s a bout time: cough bouts as a measure of severity. Speaker: Carlos Chaccour, Hyfe team
“It seems to me questionable that someone should be on a dose of corticosteroids which can cause toxicity for months, when we could see the effect of the intervention sooner, which may adjust our therapy.”
